Research on COVID-19 epidemiology and clinical outcomes
COVID-19: A Scope Research on Epidemiology and Clinical Course
This study is trying to learn more about how COVID-19 affects patients and their families to help improve treatment and prevention strategies.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 5000 (estimated) |
| Sex | All |
| Sponsor | Instituto de Saude Publica da Universidade do Porto Academic / other |
| Locations | 1 site (Porto) |
| Trial ID | NCT05046769 on ClinicalTrials.gov |
What this trial studies
This observational study aims to recruit and follow a cohort of patients diagnosed with SARS-CoV-2 infection at the University Hospital Center of 'São João'. It will evaluate the clinical course of COVID-19, identify prognostic factors, and measure the risk of reinfection. Additionally, the study will characterize patients and their household contacts to understand the dynamics of infection and transmission. The information gathered will be crucial for developing effective therapeutic solutions and preventive measures against COVID-19.
Who should consider this trial
Good fit: Ideal candidates include individuals diagnosed with SARS-CoV-2 infection and their household contacts who can provide informed consent.
Not a fit: Patients unable to provide informed consent or those not diagnosed with SARS-CoV-2 infection will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance understanding of COVID-19, leading to improved treatment and prevention strategies.
How similar studies have performed: Other studies have shown success in understanding COVID-19 dynamics, making this approach relevant and potentially impactful.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Individuals diagnosed with SARS-2-CoV-2 infection treated at CHUSJ and cohabitants able to give informed consent; * individuals who underwent the test for diagnosis of infection by SARS-CoV-2 at CHUSJ with negative result able to give informed consent. Exclusion Criteria: * Inability to obtain informed consent;
Where this trial is running
Porto
- Centro Hospitalar De São João — Porto, Portugal (Recruiting)
Study contacts
- Principal investigator: Margarida Tavares, MD, MPH — Centro Hospitalar Universitário São João & ISPUP
- Study coordinator: Margarida Tavares, MD, MPH
- Email: mftavares@ispup.up.pt
- Phone: +351222061820
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.